Why Pharmacogenetics?

• Medications are not working? They should be. Pharmacogenomics explains why this happens.

• USFDA has approved more then 120 drugs which require paharmacogenomic testing.

• Helps in preventing adverse drug reactions.

• Helps in therapy selection, doses selection, resistance & development.

Cardiology- PGx

Test Test NameCurrencyAdd To Cart
FM-CAPGx-001FMCP- Clopidogrel Sensitivity test to determine drug-metabolizer status of individual.

6,000.00 Add to cart

FM-CAPGx-002FMSTAT- Optimal dosage of Statins for individuals to avoid drug induced myopathy.

6,000.00 Add to cart

FM-CAPGx-003FMWAC- Warfarin/Acenocoumarol Dosage individualised dosage to reduce risk of accentuated responses and bleeding.

6,000.00 Add to cart

FM-CAPGx-004FMCLAS-Clopidogrel and Aspirin Sensitivity Genotyping test

6,000.00 Add to cart

FM-CAPGx-005CardioPGx mini panel test - Combo Panel determine Clopidogrel, Statins and Warfarin response and optimal dosages.

8,500.00 Add to cart

Oncology- PGx

Test NameTest DetailsCurrencyAdd To Cart
FM-OCPGx-001EGFR Mutation Detection - Predicts response to tyrosine kinase inhibitor (TKI) therapy.

6,000.00 Add to cart

FM- OCPGx -002KRAS Mutation Detection with Reflex to BRAF Codon 600 Mutation Detection

6,000.00 Add to cart

FM- OCPGx-003NRAS Mutation Detection - Predicts response to anti-EGFR and MAPK pathway therapies in a variety of malignancies.(e.g., melanoma and colorectal cancer)

6,000.00 Add to cart

FM-OCPGx-004HRAS Mutation Detection - Predicts response to anti-EGFR and MAPK pathway therapies in a variety of malignancies. (e.g. melanoma and colorectal cancer)

6,000.00 Add to cart

FM- OCPGx-005BRAF Codon 600 Mutation Detection - To predict effectiveness of therapies targeting the EGFR pathway in variety of malignancies.(e.g. Melanoma, Thyroid Cancer, Colorectal cancer)

6,000.00 Add to cart

FM- OCPGx-006PIK3CA Mutation Detection - Predicts response to anti-EGFR and AKT/mTOR pathway therapies in a variety of malignancies. (e.g. colorectal, ovarian, and breast cancer).

6,000.00 Add to cart

FM- OCPGx-007AKT1 Mutation Detection - To predict effectiveness of AKT inhibitors in variety of malignancies. (e.g. breast cancer, ovarian cancer, lung cancer and colorectal cancer)

6,000.00 Add to cart

FM- OCPGx-008UDP Glucuronosyltransferase 1A1 (UGT1A1) Genotyping - Dosage planning for individuals who will receive high-dose irinotecan, have a history of irinotecan sensitivity, or experience neutropenia while receiving irinotecan in treatment of colorectal cancer. Confirm suspected diagnosis of Gilbert syndrome.

6,000.00 Add to cart

FM- OCPGx-009ABL Kinase Domain Mutation in CML - To identify specific mutations in ABL to detect patients at high risk of Imatinib resistance.

6,000.00 Add to cart

FM- OCPGx-010cKIT (Gastrointestinal Stromal Tumor) Mutation Analysis- Detects activating mutations in c-KIT as reflex to PGDFRA. Predicts response to tyrosine kinase inhibitor (TKI) therapy.

6,000.00 Add to cart

FM- OCPGx-011PGDFRA (Gastrointestinal Stromal Tumor) Mutation Analysis - Detects activating mutations in PDGFRA. Predicts response to tyrosine kinase inhibitor (TKI) therapy.

6,000.00 Add to cart

FM- OCPGx-0125-Fluorouracil (5-FU) Mutation Analysis- Toxicity and Chemotherapeutic response analysis based on mutations in DYPD gene.

6,000.00 Add to cart

Neurology- PGx

Test NameTest DetailsCurrencyAdd To Cart
FM-NUPGx-011Carbamazepine Sensitivity - based on HLA-B Genotyping.

6,000.00 Add to cart

FM-NUPGx-012Divalproex sodium and Valproic Acid- POLG gene mutation detection for use of Divalproex sodium (contraindicated in NeuroMetabolic Syndromes.)

6,000.00 Add to cart

FM-NUPGx-013Clobazam Dosage- Individual metabolizer Status and dosage based CYP2C19 genotyping.

6,000.00 Add to cart

FM-NUPGx-014NeuroPGx mini Panel test- Drug response and dosages for use of Anti-Platelets

6,000.00 Add to cart